Studies about Cetyl Myristoleate
Cetyl myristoleate, CM or CMO, is one of the substances claimedto be extremely helpful for people suffering from arthritis. There are several scientificstudies that can confirm what some arthritis patients already experienced as positive results of the Cetyl Myristoleate treatment.
The first study with Cetyl Myristoleate on human subjectswas completed in 1995. This San Diego study showed very good results and almostall patients (46 out of the 48 involved in the study) experienced good results withthis substance. Patients reported that the pain has subsided and more than 70%of them felt less painful sensations after the use of this medication. Also, 80%of the patients have noticed significant improvement in the mobility. This studyhas some downfalls, when it comes to the number of participants and the lack ofcontrol group of patients, but it was the good starting point for some furtherresearch about Cetyl Myristoleate and the effects on people suffering fromarthritis.
In 1997, there was another study with the similar subject. Therewere much more patients involved (431) and patients received placebo, CetylMyristoleate or combination of CM, glucosamine, hydrolyzed cartilage and seacucumber. The improvement was seen in over 60% of patients using CetylMyristoleate or CM plus additional substances.
Additional studies involved patients suffering from chronicknee osteoarthritis (OA) and using CM to treat their condition. The resultsshowed significant improvement in knee range motion and some other physicalcapabilities of these patients. Because of that scientists even pronounced CMto be the alternative to non-steroidal anti-inflammatory drugs (NSAIDs) for thetreatment of osteoarthritis.
Scientists continued the studies about Cetyl Myristoleate andits use in patients diagnosed with arthritis. One of the most recent researchesincluded a large number of patients suffering from this problem and about some1800 patients were involved in the study. After the course of 16 days of using CetylMyristoleate, more than 85% of all patients have showed at least 50% recovery.
Results of the CM in Arthritis Patients
There is an increasing amount of information supporting theclaim that Cetyl Myristoleate is efficient as the treatment for arthritis. The costsof commonly prescribed treatment for arthritis usually are very high and, furthermore, many people die every year because of the NSAIDs used in thistreatment. CM is much less expensive than the conventional treatments and althoughthe information provided so far is not yet conclusive, CM products can beconsidered at least as a treatment worth of research.